Prevention Program for Problem Behaviors in Girls in Foster Care

Status Completed

Clinical Trial Summary

This study will determine the efficacy of a parent-involved intervention in preventing problem behavior in middle school girls who are currently in foster care.

Clinical Trial Description

The transition from elementary school to middle school presents a complex set of challenges for adolescents. These include increased expectations for time management and self-monitoring, renegotiation of rules and boundaries with parents, increased peer influence, and pubertal changes. For children in foster care, this transition is further complicated by issues such as a possible history of maltreatment, unpredictable changes in their living situations, and difficulty explaining their foster care background to peers and teachers. Such issues may be more serious for girls in foster care. Social problems for these girls in middle school can lead to a number of negative effects, including delinquency, substance abuse, poor school performance, mental health problems, and participation in risky sexual behavior. Despite such risks, adolescent girls are less likely to receive specialty mental health or school-based services than their male counterparts. This study is aimed at determining the effectiveness of a preventive intervention for preadolescent girls living in foster/kinship care. The intervention targets include preventing delinquency, initiation of substance use, participation in risky sexual behavior, school truancy and failure, and mental health problems. Participants were randomly assigned to receive either the preventive intervention or usual foster care services in the summer before entering middle school (typically sixth grade). The preventive intervention consisted of weekly training and support sessions for both participants and their foster or kin parents. The sessions began at study start and continued throughout participants' first year in middle school. Participants' relationship development, delinquency, school behavior and performance, sexual behavior, and substance use were assessed through questionnaires. Parenting practices were assessed through interviews. Assessments were conducted at study entry and at Months 6, 12, and 24, and 36. A new, follow-up assessment on the girls' decision making was conducted at age 14-16. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00239837
Study type	Interventional
Source	Oregon Social Learning Center
Contact
Status	Completed
Phase	N/A
Start date	December 2003
Completion date	April 2013

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02224508` - Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks	N/A
Completed	`NCT02282306` - Phone Interview to Prevent Recurring Opioid Overdoses	N/A
Completed	`NCT02375516` - Preventing Drug Abuse Among Hispanic Adolescents	N/A
Withdrawn	`NCT01275391` - cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use	Phase 1/Phase 2
Completed	`NCT01442753` - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth	N/A
Completed	`NCT00907309` - Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use	Phase 1/Phase 2
Completed	`NCT02228044` - Alcohol, Suicide and HIV Prevention for Teens in Mental Health Treatment	N/A
Withdrawn	`NCT01427465` - Brief Integrative Alcohol Interventions for Adolescents	N/A
Completed	`NCT00350909` - Brief Intervention for Drug Abusing Adolescents	Phase 2
Completed	`NCT00148031` - Improving Hepatitis C Treatment in Injection Drug Users	Phase 4
Completed	`NCT00383838` - Self-Selected Brief Alcohol Intervention for Adolescents	N/A
Completed	`NCT00722644` - Cognitive Behavioral Stress Management for HIV+ Drug Abusers	Phase 1
Completed	`NCT00451854` - Student Athlete Testing Using Random Notification	N/A
Completed	`NCT01036711` - Effects of Nicotine on Cognitive Task Performance and Brain Activity as Measured by fMRI
Terminated	`NCT02741076` - Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain	Phase 4
Completed	`NCT01035723` - Effect of Functional Genetic Polymorphisms on Brain Morphology and Function
Completed	`NCT06044363` - Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders	N/A
Recruiting	`NCT05037487` - Evaluation of Smoked THC and CBD in Men and Women	Phase 1
Recruiting	`NCT04725266` - A Family-based Intervention for Drug-abusing Adults in Hong Kong	N/A
Completed	`NCT03678051` - CBT4CBT for Women in Residential Treatment for Substance Use Disorders	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.